Creative Biolabs is offering the most comprehensive services for antibody development projects. With strict regulation and effective execution, we are dedicated to providing the most valuable solutions to complete your projects.
HighlightsCreative Biolabs is offering the most comprehensive services for antibody development projects. With strict regulation and effective execution, we are dedicated to providing the most valuable solutions to complete your projects.
HighlightsCreative Biolabs has established a broad range of platforms for developing novel antibodies or equivalents. These cutting-edge technologies enable our scientists to meet your demands from different aspects and tailor the most appropriate solution that contributes to the success of your projects.
HighlightsWith deep understanding in antibody-related realms and extensive project experience, Creative Biolabs offers a variety of references to help you learn more about our capacities and achievements, including infographic, flyer, case study, peer-reviewed publications, and all kinds of knowledge that can assist your projects. You are also welcome to contact us directly for more specific solutions.
HighlightsGet a real taste of Creative Biolabs, one of the most professional custom service providers in the world. We are committed to providing highly customized comprehensive solutions with the best quality to advance your projects.
Highlights
Loading...All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.
Sialic acid binding Ig like lectin 8 (SIGLEC8) belongs to the CD33-related Siglec family and encodes a type-I single-pass transmembrane glycoprotein. Its expression is largely restricted to specialized immune cell populations within hematopoietic tissues. Distinct from soluble immune mediators, this receptor carries multiple extracellular immunoglobulin-like domains for glycan recognition, alongside intracellular tyrosine-based regulatory motifs, and lacks intrinsic catalytic effector modules. It functions as a cell-surface inhibitory immune modulator, interacting with sialoglycan-containing partners under physiological conditions to temper excessive immune responsiveness. Insufficient functional receptor disrupts local immune restraint and amplifies inflammatory cellular outputs. SIGLEC8 provides homeostatic buffering to constrain over-active immune responses across susceptible tissue niches. Tissue microenvironments display divergent glycan profiles, requiring a diverse set of surface immune receptors to sustain balanced multicellular immune status. Membrane-embedded SIGLEC8 engages glycan-bearing molecular assemblies to counteract pathological immune activation and preserve stable local tissue physiology.
Genetic sequence changes within the SIGLEC8 locus may alter glycan-partner recognition capacity and reshape cellular immune response profiles. No other Siglec family homologue can fully replicate the combined capability of SIGLEC8 for sialoglycan ligand recognition and stable plasma-membrane anchoring. Variations in SIGLEC8 protein abundance correlate with local inflammatory status, making this receptor a valuable research subject for studying Siglec-family inhibitory receptors and allergic immune homeostasis. Localized at the cell outer membrane, SIGLEC8 participates in glycan-dependent receptor complex assembly without triggering sustained constitutive signaling cascades. Its unique domain architecture separates it from other immune inhibitory receptors, enabling both glycan sensing and selective physical contacts with tissue-derived sialoglycan partners. Loss of adequate SIGLEC8 function weakens immune inhibitory control and diminishes local inflammatory buffering capacity, reinforcing its research importance within glyco-immunology studies.
Fig. 1 Schematic topology of human Siglec‑family receptors. SIGLEC‑8 represents a type‑I single‑pass transmembrane inhibitory receptor with extracellular V‑ and C‑type Ig‑like domains and intracellular ITIM/ITIM‑like regulatory motifs.1
The biological functions of transmembrane SIGLEC8 inhibitory receptor protein are focused on sustained sialoglycan-partner interaction and tissue immune-homeostasis coordination:
Creative Biolabs offers purified SIGLEC8 membrane samples produced under unified preparation workflows, including full-length SIGLEC8 constructs and isolated extracellular-domain variants. Truncated domain fragments cannot support complete sialoglycan-partner-recognition behaviours, while full-length constructs suit research focused on Siglec-receptor-glycan interaction and cell-surface-receptor anchoring functional observation. All batches receive uniform quality screening. Functional relevant observation may only be carried out with full-length samples under simulated plasma-membrane microenvironment setups. Consistent structural features are preserved across batches to support comparative laboratory analysis across separate test groups. Full-length SIGLEC8 samples retain intact glycan-recognition-domain conformation after standardized purification, which supports reliable detection of weak and transient receptor-glycan contacts for comparative functional analysis.
Not finding the Membrane potein product you need? Contact us to start your one-stop custom service!
Creative Biolabs provides adjustable SIGLEC8 expression cell research models with varied expression levels, applicable to structural observation of single-pass Siglec-family inhibitory receptor proteins and research into sialoglycan-partner molecular interaction. Sample evaluation includes sustained target expression detection and preliminary partner-interaction observation, enabling side-by-side comparison of receptor-binding behaviours under differing expression abundances. These cell systems can pair with diverse laboratory analysis schemes to track changes in partner-engagement efficiency alongside shifting target protein levels.
Not finding the stable cell line product you need? Contact us to start your one-stop custom service!
Anti-SIGLEC8 recombinant antibodies are generated via standardized protein preparation workflows, compatible with routine laboratory detection techniques for cell-surface-membrane localization mapping and identification of receptor-glycan molecular complexes. The antibody series can work alongside common laboratory detection reagents to realize multi-dimensional observation of target distribution within inflammation-active immune-related tissue samples.
Not finding the recombinant antibody product you need? Contact us to start your one-stop custom service!
Beyond catalog products, Creative Biolabs offers specialized custom services for SIGLEC8 research:
SIGLEC8 might act as a type-I single-pass Siglec inhibitory receptor and participate in sialoglycan-partner recognition to modulate effector-cell immune restraint and allergic tissue immune homeostasis.
SIGLEC8 expression status could alter sialoglycan-partner binding efficiency and local tissue immune balance, serving as a major regulatory mediator of glycan-dependent inflammatory biological processes.
No, SIGLEC8-associated research reagents from Creative Biolabs are exclusively built for exploring Siglec-dependent glyco-immunology regulatory mechanisms, and shall not be deployed for any clinical-oriented workflows. These preparations are optimized for basic immune-biology investigation and do not satisfy performance benchmarks required for clinical implementation.
Offerings include full-length SIGLEC8 membrane protein, target-specific recombinant antibodies and tunable expression cell research models, supporting research on allergic immune homeostasis and Siglec-receptor-mediated sialoglycan partner perception.
Laboratory observation schemes may include receptor-glycan interaction related tests to analyse molecular-binding associated behaviors under simulated cell-membrane environments.
